• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于计算绝对蛋白质-配体结合自由能的水交换反应坐标。

A water-swap reaction coordinate for the calculation of absolute protein-ligand binding free energies.

机构信息

Centre for Computational Chemistry, School of Chemistry, University of Bristol, Bristol BS8 1TS, United Kingdom.

出版信息

J Chem Phys. 2011 Feb 7;134(5):054114. doi: 10.1063/1.3519057.

DOI:10.1063/1.3519057
PMID:21303099
Abstract

The accurate prediction of absolute protein-ligand binding free energies is one of the grand challenge problems of computational science. Binding free energy measures the strength of binding between a ligand and a protein, and an algorithm that would allow its accurate prediction would be a powerful tool for rational drug design. Here we present the development of a new method that allows for the absolute binding free energy of a protein-ligand complex to be calculated from first principles, using a single simulation. Our method involves the use of a novel reaction coordinate that swaps a ligand bound to a protein with an equivalent volume of bulk water. This water-swap reaction coordinate is built using an identity constraint, which identifies a cluster of water molecules from bulk water that occupies the same volume as the ligand in the protein active site. A dual topology algorithm is then used to swap the ligand from the active site with the identified water cluster from bulk water. The free energy is then calculated using replica exchange thermodynamic integration. This returns the free energy change of simultaneously transferring the ligand to bulk water, as an equivalent volume of bulk water is transferred back to the protein active site. This, directly, is the absolute binding free energy. It should be noted that while this reaction coordinate models the binding process directly, an accurate force field and sufficient sampling are still required to allow for the binding free energy to be predicted correctly. In this paper we present the details and development of this method, and demonstrate how the potential of mean force along the water-swap coordinate can be improved by calibrating the soft-core Coulomb and Lennard-Jones parameters used for the dual topology calculation. The optimal parameters were applied to calculations of protein-ligand binding free energies of a neuraminidase inhibitor (oseltamivir), with these results compared to experiment. These results demonstrate that the water-swap coordinate provides a viable and potentially powerful new route for the prediction of protein-ligand binding free energies.

摘要

准确预测蛋白质-配体的绝对结合自由能是计算科学的重大挑战之一。结合自由能衡量配体与蛋白质之间的结合强度,如果有一种算法能够准确预测结合自由能,它将成为合理药物设计的有力工具。在这里,我们提出了一种新方法的发展,该方法允许从第一性原理计算蛋白质-配体复合物的绝对结合自由能,仅使用单个模拟。我们的方法涉及使用一种新的反应坐标,该坐标通过交换与蛋白质结合的配体与等效体积的本体水来交换配体。该水交换反应坐标使用恒等约束来构建,该约束从本体水中识别占据蛋白质活性部位中配体相同体积的水分子簇。然后使用双重拓扑算法将配体从活性部位与从本体水中识别的水分子簇交换。然后使用复制交换热力学积分来计算自由能。这返回了同时将配体转移到本体水中的自由能变化,因为相同体积的本体水被转移回蛋白质活性部位。这直接是绝对结合自由能。需要注意的是,虽然该反应坐标直接模拟了结合过程,但仍需要准确的力场和足够的采样,以正确预测结合自由能。在本文中,我们介绍了该方法的细节和发展,并展示了如何通过校准用于双重拓扑计算的软核库仑和 Lennard-Jones 参数来提高水交换坐标沿的平均力势能。将最佳参数应用于神经氨酸酶抑制剂(奥司他韦)的蛋白质-配体结合自由能计算,并将这些结果与实验进行比较。这些结果表明,水交换坐标为预测蛋白质-配体结合自由能提供了一种可行且潜在强大的新途径。

相似文献

1
A water-swap reaction coordinate for the calculation of absolute protein-ligand binding free energies.一种用于计算绝对蛋白质-配体结合自由能的水交换反应坐标。
J Chem Phys. 2011 Feb 7;134(5):054114. doi: 10.1063/1.3519057.
2
Classification of water molecules in protein binding sites.蛋白质结合位点中水分子的分类
J Am Chem Soc. 2007 Mar 7;129(9):2577-87. doi: 10.1021/ja066980q. Epub 2007 Feb 9.
3
Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: application to influenza neuraminidase.使用隐式溶剂和单个分子动力学轨迹对多种配体的结合亲和力进行评分:应用于流感神经氨酸酶。
J Mol Graph Model. 2005 Oct;24(2):147-56. doi: 10.1016/j.jmgm.2005.06.003.
4
Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.水分子渗透进入 H274Y 神经氨酸酶突变体的奥司他韦结合位点导致对奥司他韦的耐药性。
J Chem Inf Model. 2009 Dec;49(12):2735-41. doi: 10.1021/ci900348n.
5
Calculation of absolute protein-ligand binding free energy using distributed replica sampling.使用分布式副本采样计算绝对蛋白质-配体结合自由能。
J Chem Phys. 2008 Oct 21;129(15):155102. doi: 10.1063/1.2989800.
6
Ab initio prediction of protein-ligand binding structures by replica-exchange umbrella sampling simulations.从头开始通过复制交换伞状采样模拟预测蛋白质 - 配体结合结构。
J Comput Chem. 2011 Oct;32(13):2810-21. doi: 10.1002/jcc.21860. Epub 2011 Jun 27.
7
Protein-ligand binding free energy calculation by the Smooth Reaction Path Generation (SRPG) Method.通过平滑反应路径生成(SRPG)方法进行蛋白质-配体结合自由能计算。
J Chem Inf Model. 2009 Aug;49(8):1944-51. doi: 10.1021/ci9002156.
8
Grand canonical free-energy calculations of protein-ligand binding.蛋白质-配体结合的巨正则自由能计算。
J Chem Inf Model. 2009 Apr;49(4):934-43. doi: 10.1021/ci8004397.
9
Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.结合自由能计算的检验方法:配体与HIV蛋白酶结合的LRA、LIE、PDLD-LRA及PDLD/S-LRA计算
Proteins. 2000 Jun 1;39(4):393-407.
10
Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.一种用于预测一组醛糖还原酶抑制剂结合相对自由能的自动化程序的验证。
Bioorg Med Chem. 2007 Dec 15;15(24):7865-77. doi: 10.1016/j.bmc.2007.08.019. Epub 2007 Aug 22.

引用本文的文献

1
Identification of potent antibacterial inhibitors targeting methyltransferase Mtr1/TrmD in Haemophilus influenzae via molecular dynamics simulations.通过分子动力学模拟鉴定针对流感嗜血杆菌中甲基转移酶Mtr1/TrmD的强效抗菌抑制剂
PLoS One. 2025 Aug 28;20(8):e0328497. doi: 10.1371/journal.pone.0328497. eCollection 2025.
2
Multisite λ-Dynamics for Protein-DNA Binding Affinity Prediction.用于蛋白质 - DNA 结合亲和力预测的多位点 λ 动力学
J Chem Theory Comput. 2025 Apr 8;21(7):3536-3544. doi: 10.1021/acs.jctc.4c01408. Epub 2025 Mar 24.
3
Discovering broad-spectrum inhibitors for SARS-CoV-2 variants: a cheminformatics and biophysical approach targeting the main protease.
发现针对新冠病毒变异株的广谱抑制剂:一种针对主要蛋白酶的化学信息学和生物物理学方法
Front Pharmacol. 2025 Feb 5;16:1459581. doi: 10.3389/fphar.2025.1459581. eCollection 2025.
4
Identification and study of new NF-κB-inducing kinase ligands derived from the imidazolone scaffold.源自咪唑啉酮支架的新型核因子κB诱导激酶配体的鉴定与研究。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400614. doi: 10.1002/ardp.202400614. Epub 2024 Nov 27.
5
Riddelline from Tamarix articulate as a potential anti-bacterial lead compound for novel antibiotics discovery: A comprehensive computational and toxicological studies.胡杨亭利定作为一种有潜力的新型抗生素先导化合物的抗菌活性:全面的计算和毒理学研究。
PLoS One. 2024 Nov 14;19(11):e0310319. doi: 10.1371/journal.pone.0310319. eCollection 2024.
6
Structural Dynamics of P-Rex1 Complexed with Natural Leads Establishes the Protein as an Attractive Target for Therapeutics to Suppress Cancer Metastasis.P-Rex1 复合物与天然配体的结构动力学研究确立了该蛋白作为抑制癌症转移治疗靶点的吸引力。
Biomed Res Int. 2023 Dec 7;2023:3882081. doi: 10.1155/2023/3882081. eCollection 2023.
7
Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study.有前景的甲硫氨酸氨基肽酶抑制剂的鉴定:综合虚拟筛选与动力学模拟研究的联合研究
Saudi Pharm J. 2023 Sep;31(9):101745. doi: 10.1016/j.jsps.2023.101745. Epub 2023 Aug 9.
8
A cheminformatics-biophysics correlate to identify promising lead molecules against matrix metalloproteinase-2 (MMP-2) enzyme: A promising anti-cancer target.一种用于识别针对基质金属蛋白酶-2(MMP-2)酶的潜在先导分子的化学信息学-生物物理学关联:一个有前景的抗癌靶点。
Saudi Pharm J. 2023 Jul;31(7):1244-1253. doi: 10.1016/j.jsps.2023.05.010. Epub 2023 May 16.
9
Targeting ME49 TgAPN2: A Bioinformatics Approach for Antiparasitic Drug Discovery.针对 ME49TgAPN2:一种用于抗寄生虫药物发现的生物信息学方法。
Molecules. 2023 Apr 3;28(7):3186. doi: 10.3390/molecules28073186.
10
Proteome-Wide Screening of Potential Vaccine Targets against .针对……的潜在疫苗靶点的全蛋白质组筛选
Vaccines (Basel). 2023 Jan 25;11(2):263. doi: 10.3390/vaccines11020263.